FFF Enterprises, a plasma products distributor, implemented Intentia’s drug pedigree system to assure regulatory compliance and the continued effectiveness of its supply channel model. A pedigree system certifies the entire channel a medication has traveled from the manufacturer to the healthcare provider.
Pedigrees will be required by Florida effective July 2006. Two other states have similar legislation ready to take effect, and 23 more are in the process of considering similar laws. The goal is to cut down instances of drug tampering, counterfeiting and diversion.
The concept of a drug pedigree is to provide a comprehensive record of where the product has been from manufacturer to healthcare provider, and FFF is completely committed to this effort, said Keith Sinclair, director of logistics at FFF.
When we began to build this system, we realized that we needed to capture and retain within Movex a higher level of detail on product movement. Movex is very flexible and allowed us to enable greater traceability.
Content from our partners
